Evidence map›Paper›PMID 39987144›Full record

ArticleScientific reports2025

Preliminary study demonstrating cancer cells detection at the margins of whole glioblastoma specimens with Raman spectroscopy imaging.

François Daoust, Frédérick Dallaire, Hugo Tavera, Katherine Ember, Marie-Christine Guiot, Kevin Petrecca, Frederic Leblond

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

François DaoustPolytechnique Montréal, Montreal, Canada.
Frédérick DallairePolytechnique Montréal, Montreal, Canada.
Hugo TaveraPolytechnique Montréal, Montreal, Canada.
Katherine EmberPolytechnique Montréal, Montreal, Canada.
Marie-Christine GuiotDivision of Neuropathology, Department of Pathology, Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada.
Kevin PetreccaMontreal Neurological Institute-Hospital, McGill University, Montreal, Canada.
Frederic LeblondPolytechnique Montréal, Montreal, Canada. frederic.leblond@polymtl.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intraoperative Raman spectroscopy uses near-infrared laser light to gain molecular information without causing damage. It can be used in vivo or ex vivo without exogenous contrast agents. Clinically, the technique was primarily used with machine learning for in situ tumor detection with fiberoptics probes analyzing tissue at sub-millimeter scales one point at the time. Here we report the development of a whole-specimen spectroscopic imaging system designed to detect cancer cells at the margins of surgical specimens. The system has a field of view covering a square area of side one centimeter with a pixel size of a quarter of a millimeter . First, a tumor detection model was developed from data acquired using a point-probe in 24 glioblastoma patients that had a detection sensitivity of 90% and a specificity of 95%. That model was then used to produce cancer prediction maps of nine glioblastoma specimens from five patients with validation based on histopathology analyses. The results preliminarily demonstrate the instrument was able to detect tissue areas associated with cancer cells from the Raman peaks associated with the amino acids phenylalanine and tryptophan as well as the relative concentration of lipids and proteins linked with deformations of the CH

Indexed as

Brain NeoplasmsGlioblastomaSpectrum Analysis, RamanFemaleHumansMargins of Excision

Identifiers

PMID39987144
PMCPMC11846850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.